Here are six notes.
1. Medtronic reported fourth quarter 2018 worldwide revenue of $8.14 billion, a 2.9 percent year-over-year increase. Adjusting for Medtronic’s second-quarter divestments and a $315 million positive impact from foreign currency, worldwide revenue grew 6.5 percent year over year.
2. As reported, fourth-quarter GAAP net income was $1.46 billion. Fourth-quarter non-GAAP net income increased 6 percent to $1.94 billion.
3. Fourth-quarter U.S. revenue decreased 4.9 percent as reported, but increased 5.3 percent year over year when adjusting for the divestiture.
4. Medtronic’s fiscal year 2018 revenue of $29.95 billion increased 4.6 percent, adjusting for the divestiture, acquisitions and foreign currency impact.
5. Cash flow from operations for fiscal year 2018 was $4.7 billion.
6. Medtronic’s Minimally Invasive Therapies Group, which includes the Surgical Innovations and Respiratory, Gastrointestinal & Renal divisions, reported worldwide fourth-quarter revenue of about $2.24 billion.
More articles on supply chain:
4 major trends to watch in the orthopedic medical device market
Judge shuts down 312 patient allegations that DePuy’s hip replacement device was defective — 6 insights
How ASCs can eliminate lurking OR inefficiencies to drive down costs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.